Azithromycin in one week quadruple therapy for H pylori eradication in Iran

doi:10.3748/wjg.v12.i28.4553

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2513)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

314

HTML

2055

Tables (1-2)

144

Sum=2513

Jul 28, 2006 (publication date) through Sep 3, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 28, 2006; 12(28): 4553-4556
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4553

Table 2 Complications of drugs in H pylori treatment

Complication	B-OAM-2 wk regimen	B-OAzM-1 wk regimen	P value²
n	69³	57³
Diarrhea (%)	4 (5.7)	4 (7)
Vomiting (%)	5 (7.2)¹	4 (7)¹
Abdominal pain (%)	7 (10.1)	5 (8.7)
Bad taste (%)	7 (10.1)	5 (8.7)
Anal pain (%)	0	2 (3.5)
Total (%)	23 (33.3%)	20 (35%)	0.83

¹Three patients of group "A" and two patients of group "B" excluded from the study for severe vomiting.; ²χ²; ³ All patients except lost to follow up cases.

Citation: Mousavi S, Toussy J, Yaghmaie S, Zahmatkesh M. Azithromycin in one week quadruple therapy for H pylori eradication in Iran. World J Gastroenterol 2006; 12(28): 4553-4556
URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4553.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i28.4553